Self-administered and passive cocaine infusions produce different effects on corticosterone concentrations in the medial prefrontal cortex (MPC) of rats

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 1, 2009, Pages 163-168

  Palamarchouk, Vitaly ^a   Smagin, Gennady ^a   Goeders, Nicholas E ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Basolateral amygdala; Cocaine; Corticosterone; Medial prefrontal cortex; Microdialysis; Nucleus accumbens; Self administration; Yoked

Indexed keywords

COCAINE; CORTICOSTERONE; CORTICOTROPIN; SODIUM CHLORIDE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CANNULATION; CATHETERIZATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG SELF ADMINISTRATION; HISTOLOGY; HORMONE DETERMINATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ADRENOCORTICOTROPIC HORMONE; AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING, OPERANT; CORTICOSTERONE; INFUSIONS, INTRAVENOUS; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; ORGAN SPECIFICITY; PREFRONTAL CORTEX; RATS; RATS, WISTAR; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; TIME FACTORS;

RATTUS;

EID: 70349200579     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.08.003     Document Type: Article

References (39)

1. Brady K.T., and Sinha R. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatry 162 (2005) 1483-1493
2. Carroll F.I., Howell L.L., and Kuhar M.J. Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. J Med Chem 42 (1999) 2721-2736
3. Carson S.W., Ousmanou A.D., and Hoyler S.L. Emerging significance of P-glycoprotein in understanding drug disposition and drug interactions in psychopharmacology. Psychopharmacol Bull 36 (2002) 67-81
4. Droste S.K., de Groote L., Lightman S.L., Reul J.M., and Linthorst A.C. The ultradian and circadian rhythms of free corticosterone in the brain are not affected by gender: an in vivo microdialysis study in Wistar rats. J Neuroendocrinol 21 (2009) 132-140
5. Dworkin S.I., Mirkis S., and Smith J.E. Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drug. Psychopharmacology 117 (1995) 262-266
6. Engelhardt D., Dorr G., Jaspers C., and Knorr D. Ketoconazole blocks cortisol secretion in man by inhibition of adrenal 11 beta-hydroxylase. Klin Wochenschr 63 (1985) 607-612
7. Goeders N.E. A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 22 (1997) 237-259
8. Goeders N.E. Stress and cocaine addiction. J Pharmacol Exp Ther 301 (2002) 785-789
9. Goeders N.E. The HPA axis and cocaine reinforcement. Psychoneuroendocrinology 27 (2002) 13-33
10. Goeders N.E. The impact of stress on addiction. Eur Neuropsychopharmacol 3 (2003) 435-441
11. Goeders N.E. Stress, motivation and drug addiction. Curr Dir Psychol Sci 13 (2004) 33-35
12. Goeders N.E., and Clampitt D.M. Potential role for the hypothalamo-pituitary-adrenal axis in the conditioned reinforcer-induced reinstatement of extinguished cocaine seeking in rats. Psychopharmacology 161 (2002) 222-232
13. Goeders N.E., and Guerin G.F. Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats. Brain Res 722 (1996) 145-152
14. Goeders N.E., and Guerin G.F. Effects of the combination of metyrapone and oxazepam on cocaine and food self-administration in rats. Pharmacol Biochem Behav 91 (2008) 181-189
15. Goeders N.E., Peltier R.L., and Guerin G.F. Ketoconazole reduces low dose cocaine self-administration in rats. Drug Alcohol Depend 53 (1998) 67-77
16. Haleem D.J., Kennett G., and Curzon G. Adaptation of female rats to stress: shift to male pattern by inhibition of corticosterone synthesis. Brain Res 458 (1988) 339-347
17. Hemby S.E., Co C., Koves T.R., Smith J.E., and Dworkin S.I. Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacology 133 (1997) 7-16
18. Koob G., and Kreek M.J. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164 (2007) 1149-1159
19. Koob G.F., Cole B.J., Swerdlow N.R., Le Moal M., and Britton K.T. Stress, performance, and arousal: focus on CRF. NIDA Res Monogr 97 (1990) 163-176
20. Koob G.F., Sannam P.P., and Bloom F.E. Neuroscience of addiction. Neuron 21 (1998) 467-476
21. Li C.S., and Sinha R. Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction. Neurosci Biobehav Rev 32 (2008) 581-597
22. Linthorst A.C., and Reul J.M. Stress and the brain: solving the puzzle using microdialysis. Pharmacol Biochem Behav 90 (2008) 163-173
23. Linthorst A.C., van Giersbergen P.L., Gras M., Versteeg D.H., and de Jong W. The nigrostriatal dopamine system: role in the development of hypertension in spontaneously hypertensive rats. Brain Res 639 (1994) 261-268
24. Linthorst A.C., Flachskamm C., Muller-Preuss P., Holsboer F., and Reul J.M. Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study. J Neurosci 15 (1995) 2920-2934
25. Linthorst A.C., Flachskamm C., and Reul J.M. Water temperature determines neurochemical and behavioural responses to forced swim stress: an in vivo microdialysis and biotelemetry study in rats. Stress 11 (2008) 88-100
26. Loose D.S., Stover E.P., and Feldman D. Ketoconazole binds to glucocorticoid receptors and exhibits glucocorticoid antagonist activity in cultured cells. J Clin Invest 72 (1983) 404-408
27. Majewska M.D. HPA axis and stimulant dependence: an enigmatic relationship. Psychoneuroendocrinology 27 (2002) 5-12
28. Moldow R.L., and Fischman A.J. Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone. Peptides 8 (1987) 819-822
29. National Drug Threat Assessment 2009, http://www.usdoj.gov/ndic/pubs31/31379/cocaine.htm#Overview, 2009.
30. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press
31. Rivier C., and Vale W. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res 422 (1987) 403-406
32. Sarnyai Z., Shaham Y., and Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 53 (2001) 209-243
33. Smith J.E., Co C., Freeman M.E., and Lane J.D. Brain neurotransmitter turnover correlated with morphine-seeking behavior of rats. Pharmacol Biochem Behav 16 (1982) 509-519
34. Smith J.E., Koves T.R., and Co C. Brain neurotransmitter turnover rates during rat intravenous cocaine self-administration. Neuroscience 117 (2003) 461-475
35. Uhr M., Holsboer F., and Müller M.B. Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J Neuroendocrinol 14 (2002) 753-759
36. Vaalburg W., Hendrikse N.H., Elsinga P.H., Bart J., and van Waarde A. P-glycoprotein activity and biological response. Toxicol Appl Pharmacol 207 2 Suppl (2005) 257-260
37. Vocci F.J., and Montoya I.D. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence. Curr Opin Psychiatry 22 (2009) 263-268
38. Vocci F.J., Acri J., and Elkashef A. Medication development for addictive disorders: the state of the science. Am J Psychiatry 162 (2005) 1432-1440
39. Winhusen T., and Somoza E. The HPA axis in cocaine use: implications for pharmacotherapy. J Addict Dis 20 (2001) 105-119